Ultrasound Neuroimmune Modulation in Adults With Rheumatoid Arthritis
Part of paid clinical trials in Colleyville, Texas.
- Sponsor
- Surf Therapeutics
- Study ID
- NCT07293871
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Active treatment — DEVICEDaily active ultrasound stimulation
- Sham (No Treatment) — DEVICEDaily sham ultrasound stimulation
Study Details
This two-stage, multicenter clinical trial is designed to evaluate the feasibility, safety, and preliminary efficacy of splenic ultrasound stimulation to activate immune-neuromodulation (SUSTAIN) in patients with rheumatoid arthritis (RA) and at least moderate disease activity. The findings from this trial will directly inform the design and power calculations for a future pivotal trial by identifying an appropriate effect size and confirming protocol feasibility and safety.
Key Dates
- First listed
- Dec 19, 2025
- Start date
- Mar 20, 2026
- Status verified
- Jul 2026
- Primary completion
- Jan 31, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: TreatmentDaily active stimulation for 8 weeks
- Sham Comparator: ControlDaily sham stimulation, for 8 weeks, which will look and feel the same as active stimulation, but with no ultrasound energy entering the body
Primary Outcome Measure
Incidence of Adverse Events [ Time Frame: 12 weeks ]
Central Contacts
- Alexander Sackeim, MD9145237345
- Usman Asaf9296027717
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Precision Comprehensive Clinical Research Solutions | Colleyville | Texas | 75034 | Dhiman Basu, MD (PRINCIPAL_INVESTIGATOR) |
| Rheumatology Associates | Dallas | Texas | 75231 | Robert Jenkins, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Precision Comprehensive Clinical Research Solutions | Irving | Texas | 75061 | Renuka Basavaraju, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Colleyville, TX
By condition
Related Studies
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Sacramento, California
- RA-PRO PRAGMATIC TRIALPHASE3 · Recruiting · University of Alabama at Birmingham · Auburn, Alabama
- Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint InhibitorsRecruiting · M.D. Anderson Cancer Center · Houston, Texas
- ConsideRAte Study - Splenic Stimulation for RARecruiting · Galvani Bioelectronics · Covina, California